Sligo.ie
  • Live
    • Live
    • Work
    • Housing
    • Your Council
    • Living Essentials
    • Getting Around
    • Community
    • Sports
    • Learning
    • Things To Do
    • Latest Articles
  • Invest
    • Invest
    • Our Companies
    • Education
    • Innovation & Startups
    • Business Supports
    • Social Enterprise
    • Conference Facilities
    • Latest Articles
  • Visit
    • Visit
    • Diaspora
    • Getting Here
    • Latest Articles
  • Menu Menu

Western Development Commission invests €500,000 in Sligo-based Nektr Technologies

The Western Development Commission (WDC) has invested €500,000 in Nektr Technologies, the Sligo-based biotech company developing an anti-bacterial, anti-fungal and anti-viral synthetic compound with far-reaching applications in the areas of human and animal health.

A3IS, Nektr’s technology, is a highly potent synthetic antimicrobial compound, which has demonstrated efficacy against a large number of multi-drug resistant pathogens (including many on the World Health Organisation list of critical pathogens) with no resistance – meaning it provides a potential answer to the global challenge of antibiotic resistance and overuse. Because of the widespread use of antibiotics, the infectious bacteria they were designed to counter have adapted to them, making antibiotics increasingly less effective as a treatment than they once were

In terms of human healthcare, Nektr is currently employing the technology in the areas of onychomycosis (a fungal infection of the nails), anti-microbial resistance (AMR), dermatological challenges, nasal decontamination and medical device coatings. It is also exploring other potential areas of application in human and animal healthcare as well as potential improvements to the human food chain and to the environment.

The WDC investment is part of a €1 million fundraising round to support further product development and commercialisation. This funding round follows on from previous funding raised from private sources and Enterprise Ireland. Nektr’s CEO, Frank Boyle, previously founded medical device company ProTek Medical, which he sold to Koch Industries in 2016.

The WDC Investment Fund has helped support the position of the West of Ireland as a start-up hub for indigenous medtech and life science companies, building on the region’s reputation as a global centre of excellence. Gillian Buckley, Investment Manager WDC

The Western Development Commission’s €75m Investment Fund is an Evergreen investment fund, providing seed and venture capital and loan finance to SMEs, micro-enterprises, social enterprises and community projects across the Western Region. To date, it has invested in more than 200 enterprises supporting over 5,000 jobs and leveraging over a quarter of a billion euros of investment for companies in the region.

Gillian Buckley, Investment Manager with the Western Development Commission, said:

“The WDC Investment Fund has helped support the position of the West of Ireland as a start-up hub for indigenous medtech and life science companies, building on the region’s reputation as a global centre of excellence. Nektr Technologies is our 36th life science investment, making the WDC Investment Fund one of the largest medtech/life science investors in the country. The WDC is an impact investor so we seek not only a financial return on investment but also a socio-economic impact. Nektr Technologies offers both, it will support high quality jobs in Sligo as well as addressing significant healthcare issues.

The significant investment by the WDC in the current fundraising of €1 million will allow Nektr to capitalise on the commercial opportunities that it currently has, further develop the other potential applications we have identified and add additional resources to the business to assist its growth.

Frank Boyle, CEO of Nektr Technologies, said:

“Nektr is currently concluding a Phase 3 Pharmaceutical Clinical Trial on the efficacy of A3IS as a novel and cost-effective treatment for onychomychosis (Fungal Nail Disease). During the course of the trial, we came across a lot of other opportunities for deploying the technology. The significant investment by the WDC in the current fundraising of €1 million will allow Nektr to capitalise on the commercial opportunities that it currently has, further develop the other potential applications we have identified and add additional resources to the business to assist its growth.”

Tomás Ó Síocháin, CEO of the Western Development Commission, said:

“The development of Nektr’s A3IS synthetic compound has the potential to address critical global issues in the areas of human and animal health and the environment. It also emphasises Sligo’s growing reputation as a hub for technological innovation and entrepreneurship.”

For more information or to arrange interviews, contact Allan Mulrooney, WDC Head of Communications at 087 3343713

Live Articles

  • Look Local Look SligoDecember 15, 2022 - 12:24 pm
  • Sligo Benefits from Community Monuments Fund 2022June 21, 2022 - 6:18 pm
  • The Book of SligoJune 21, 2022 - 6:11 pm
  • Bolt launches 100 e-bike trial in SligoJune 20, 2022 - 3:50 pm
  • Harnessing the Power of Sligo’s DiasporaJune 17, 2022 - 9:27 am

More Live…

Invest Articles

  • An Chroí Digital HubSeptember 30, 2022 - 3:20 pm
  • Trailstone announces expansion into IrelandJuly 5, 2022 - 3:20 pm
  • New Sligo. Brand Video – “Why Not Make Sligo Yours?”June 29, 2022 - 10:09 am
  • Global spirits company Sazerac announces purchase of Sligo’s Lough Gill DistilleryJune 22, 2022 - 11:20 am
  • Amcor announces the creation of 75 jobs in Sligo with expansion of healthcare packaging capabilities in EuropeApril 25, 2022 - 3:20 pm

More Invest…

Visit Articles

  • Visit Sligo attends Holiday World Show in DublinJanuary 25, 2023 - 1:17 pm
  • Launch of Visit Sligo Marketing CampaignJanuary 25, 2023 - 1:04 pm
  • Look Local Look SligoDecember 15, 2022 - 12:24 pm
  • Spanish Armada IrelandSeptember 27, 2022 - 4:48 pm
  • County Sligo Heritage and Genealogy CentreSeptember 27, 2022 - 4:20 pm

More Visit…

We’d love to keep you up to date with news, events and all things Sligo. Subscribe here.

Sign Up
Interests
Sligo: Live Invest Visit News
Sligo Diaspora
Privacy
I have read and agree to the Sligo.ie privacy policy.

Live

  • Work
  • Housing
  • Living Essentials
  • Getting Around
  • Community
  • Sports
  • Learning
  • Things To Do
  • Latest Articles

Invest

  • Our Companies
  • Education
  • Innovation & Startups
  • Business Supports
  • Conference Facilities
  • Latest Articles

Visit

  • Explore Sligo’s Attractions
  • Getting Here

Enquiries

  • General Enquiries
  • Our Brand Our Story

Sligo IE Logo Sligo County Council Logo

© Sligo.ie
  • Twitter
  • Facebook
  • Instagram
  • Youtube
  • Home
  • Privacy
Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept All CookiesManage PreferencesEssential Cookies

Cookie and Privacy Settings



Our use of cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

For more detailed information about the cookies we use, see our Cookies Page

Essential Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, you cannot refuse them without impacting how our site functions. You can block or delete them by changing your browser settings and force blocking all cookies on this website.

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Privacy
Accept settingsHide notification only
Open Message Bar